Environment and lupus-related diseases

Lupus

Volumn 21, Issue 3, 2012, Pages 241-250

  Zandman Goddard, G ^a,b   Solomon, M ^b,c   Rosman, Z ^a   Peeva, E ^d   Shoenfeld, Y ^b,c  

^a Wolfson Medical Center   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

antiphospholipid syndrome; cutaneous lupus; drug induced lupus; mixed connective tissue disease; systemic lupus erythematosus; undifferentiated connective tissue disease

Indexed keywords

ADALIMUMAB; ANTINUCLEAR ANTIBODY; CHLORPROMAZINE; DOUBLE STRANDED DNA; ESTROGEN; ETANERCEPT; HEPATITIS B VACCINE; HYDRALAZINE; INFLIXIMAB; INFLUENZA VACCINE; ISONIAZID; METHYLDOPA; MINOCYCLINE; PESTICIDE; PHTHALIC ACID; PROCAINAMIDE; QUINIDINE; RO ANTIBODY; STEROID; WART VIRUS VACCINE;

ACUTE CUTANEOUS LUPUS ERYTHEMATOSUS; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNITY; CIGARETTE SMOKING; CYTOTOXICITY; DISCOID LUPUS ERYTHEMATOSUS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; HORMONAL THERAPY; HUMAN; IMMUNOPATHOGENESIS; LICHENOID; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS TUMIDUS; LUPUS LIKE SYNDROME; MACULOPAPULAR RASH; MEDLINE; MENTAL STRESS; MIXED CONNECTIVE TISSUE DISEASE; NONHUMAN; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; SEX REASSIGNMENT; STEROID THERAPY; SUNLIGHT; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ULTRAVIOLET RADIATION; UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE; VITAMIN D DEFICIENCY;

ANIMALS; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SUNLIGHT; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 84856764863     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311426568     Document Type: Review

References (74)

1. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J. 2008 ; 10: 8-12 (Pubitemid 351649455)
2. Shoenfeld Y, Gilburd B, Abu-Shakra M, et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr Med Assoc J. 2008 ; 10: 3-7 (Pubitemid 351649454)
3. Sontheimer RD. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev. 2005 ; 4: 253-263 (Pubitemid 40884542)
4. Zandman-Goddard G, Solomon M, Barzilai A, Shoenfeld Y. Lupus erythematosus tumidus induced by sex reassignment surgery. J Rheumatol. 2007 ; 34: 1938-1940 (Pubitemid 350067659)
5. Peeva E, Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett. 2005 ; 101: 123-143 (Pubitemid 41368071)
6. Bernier MO, Mikaeloff Y, Hudson M, Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Rheum. 2009 ; 61: 476-481
7. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev. 2007 ; 6: 366-372 (Pubitemid 46810396)
8. Sontheimer RD, Henderson CL, Grau RH. Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient oriented translational clinical investigation. Arch Dermatol Res. 2009 ; 301: 65-70
9. Furukawa F, Muto M. Ethnic differences in immunogenetic features and photosensitivity of cutaneous lupus erythematosus. Arch Dermatol Res. 2009 ; 301: 111-115
10. Lehmann P, Homey B. Clinic and pathophysiology of photosensitivity in lupus erythematosus. Autoimmun Rev. 2009 ; 8: 456-461
11. Miot HA, Bartoloi Miot LD, Haddad GR. Association between discoid lupus erythematosus and cigarette smoking. Dermatology. 2005 ; 211: 118-122 (Pubitemid 41160246)
12. Boeckler P, Cosnes A, Frances C, Hedelin G, Lipsker D. Association of cigarette smoking but not alcohol consumption with cutaneous lupus erythematosus. Arch Dermatol. 2009 ; 145: 1012-1016
13. Stojanovich L. Stress and autoimmunity. Autoimmun Rev. 2010 ; 9: 271-276
14. Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A. Drug-induced lupus erythematosus. Autoimmunity. 2005 ; 38: 507-507
15. Dedeoglu F. Drug-induced autoimmunity. Curr Op Rheumatol. 2009 ; 21: 547-551
16. Borchers AT, Keen CL, Gershwin ME. Drug-induced lupus. Ann N Y Acad Sci. 2007 ; 1108: 166-182 (Pubitemid 47528730)
17. Costa MF, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum. 2008 ; 37: 381-387 (Pubitemid 351734520)
18. Ramos-Casals M, Brito-Zeron P, Munoz S, et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore). 2007 ; 86: 242-251 (Pubitemid 47067483)
19. Katz U, Zandman-Goddard G. Drug-induced lupus: an update. Autoimmunity Rev. 2010 ; 10: 46-50
20. Tsay GJ, Zouali M. Toxicogenomics-A novel opportunity to probe lupus susceptibility and pathogenesis. Int Immunopharmacol. 2008 ; 8: 1330-1337
21. Jonsen A, Bengtsson A, Nived O, Truedsson L, Sturfelt G. Gene-environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity. 2007 ; 40: 613-617
22. Yung R, Powers D, Johnson K, et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus-like disease in syngeneic mice. J Clin Invest. 1996 ; 97: 2866-2871 (Pubitemid 26197100)
23. Ghoreishi M, Dutz JP. Murine models of cutaneous involvement in lupus erythematosus. Autoimmun Rev. 2009 ; 8: 484-487
24. Zouali M. Receptor editing and receptor revision in rheumatic autoimmune diseases. Trends Immunol. 2008 ; 29: 103-109
25. Maddison PJ. Mixed connective tissue disease: overlap syndromes. Baillieres Clini Rheumatol. 2000 ; 14: 111-124 (Pubitemid 30353027)
26. Aringer M, Steiner G, Smolen JS. Does mixed connective tissue disease exist? Yes. Rheum Dis Clin North Am. 2005 ; 30: 411-420 (Pubitemid 41111545)
27. Nimelstein SH, Brody S, McShane D, Holman HR. Mixed connective tissue disease: a subsequent evaluation of the original 25 patients. Medicine (Baltimore). 1980 ; 59: 239-248 (Pubitemid 10093114)
28. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003 ; 349: 1526-1533 (Pubitemid 37255038)
29. Zold E, Szodoray P, Gaal J, et al. Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther. 2008 ; 10: R153 - R153
30. Garabrant DH, Dumas C. Epidemiology of organic solvents and connective tissue disease. Arthritis Res. 2000 ; 2: 5-15 (Pubitemid 32223679)
31. Lacey JV, Garabrant DH, Laing TJ, et al. Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD). Am J Epidemiol. 1999 ; 149: 761-770 (Pubitemid 29180785)
32. Yin H, Borghi MO, Delgado-Vega AM, Tincani A, Meroni PL, Alarcon-Riquelme ME. Association of STAT4 and BLK, but not BANK1 or IRF5, with primary antiphospholipid syndrome. Arthritis Rheum. 2009 ; 60: 2468-2471
33. Zandman-Goddard G, Blank M, Shoenfeld Y The Antiphospholipid syndrome II. Autoimmune Thromboses. Asherson RA Cervera R Shoenfeld Y Piette JC, ed. Amsterdam: Elsevier ; 2002: 343-358.
34. Blank M, Eisenstein M, Asherson RA, Cervera R, Shoenfeld Y Infection and Autoimmunity. Shoenfeld Y Rose N, ed. Amsterdam: Elsevier ; 2004: 473-490.
35. Zinger H, Sherer Y, Goddard G, et al. Common infectious agents prevalence in antiphospholipid syndrome. Lupus. 2009 ; 18: 1149-1153
36. Zandman-Goddard G, Berkun Y, Barzilai O, et al. Neuropsychiatric lupus and infectious triggers. Lupus. 2008 ; 17: 380-384 (Pubitemid 351798712)
37. Zandman-Goddard G, Berkun Y, Barzilai O, et al. Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci. 2009 ; 1173: 658-663
38. Shoenfeld Y, Meroni PL, Toubi E. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale?. Curr Opin Rheumatol. 2009 ; 21: 495-500
39. Soltesz P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007 ; 6: 379-386 (Pubitemid 46810399)
40. Zandman-Goddard G, Chapman J, Shoenfeld Y. Autoantibodies involved in neuropsychiatric SLE and antiphospholipid Syndrome. Semin Arthritis Rheum. 2007 ; 36: 297-315 (Pubitemid 46517634)
41. Krause I, Lev S, Fraser A, et al. Close association between valvular heart disease and central nervous system manifestations in the antiphospholipid syndrome. Ann Rheum Dis. 2005 ; 60: 1490-1493 (Pubitemid 41623863)
42. Parks CG, Walitt BT, Pettinger M, et al. Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the women's health initiative observational study. Arthritis Care Res (Hoboken). 2011 ; 63: 184-194
43. S. Cooper G, Wither J, Bernatsky S, et al. Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents. Rheumatology. 2010 ; 49: 2172-2180
44. Sherer Y, Gorstein A, Frtizler MJ, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum. 2004 ; 34: 501-537 (Pubitemid 40288129)
45. Orbach H, Agmon-Levin N, Shoenfeld Y, Zandman-Goddard G. Infections and vaccines and autoimmune diseases of the adult. Discov Med. 2010 ; 9: 90-97
46. Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-'vaccinosis': a dangerous liaison?. J Autoimmun. 2000 ; 14: 1-10
47. Agmon-Levin N, Kivity S, Shoenfeld Y. Influenza vaccine and autoimmunity. Isr Med Assoc J. 2009 ; 11: 183-185
48. Klumb E, Pinto A, Jesus G, et al. Are women with lupus at higher risk of HPV infection?. Lupus. 2010 ; 19: 1485-1491
49. Rubtsov AV, Rubtsova K, Kappler JW, Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev. 2010 ; 9: 494-498
50. Zhang Y, Saha S, Rosenfeld G, Gonzalez J, Pepeljugoski KP, Peeva E. Raloxifene modulates estrogen-mediated B cell autoreactivity in NZB/W F1 mice. J Rheumatol. 2010 ; 37: 1646-1657
51. Sanchez-Guerrero J, Gonzalez-Perez M, Durand-Carbajal M, et al. Menopause hormonal therapy in women with SLE. Arthritis Rheum. 2007 ; 56: 3070-3070
52. Li J, McMurray RW. Effects of chronic exposure to DDT andTCDD on disease activity in murine systemic lupus erythematosus. Lupus. 2009 ; 18: 941-949
53. Peeva E, Venkatesh J, Diamond B. Tamoxifen blocks estrogen-induced B cell maturation but not survival. J Immunol. 2005 ; 175: 1415-1423 (Pubitemid 41023040)
54. González DA, Díaz BB, Rodríguez Pérez Mdel C, Hernández AG, Chico BN, de León AC. Sex hormones and autoimmunity. Immunol Lett. 2010 ; 133: 6-13
55. Klein RS, Sayre RM, Dowdy JC, Werth VP. The risk of ultraviolet radiation exposure from indoor lamps in lupus erythematosus. Autoimmun Rev. 2009 ; 8: 320-324
56. Stern RS, Docker W. An exacerbation of SLE after visiting a tanning salon. JAMA. 1986 ; 255: 3120-3120
57. Bilj M, Reefman E, Limburg PC, Kallenberg CGM. Inflammatory clearance of apoptotic cells after UVB challenge. Autoimmunity. 2007 ; 40: 244-248 (Pubitemid 46845515)
58. Souberbielle JC, Body JJ, Lappe JM, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010 ; 9: 709-715
59. Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol. 2008 ; 20: 532-537
60. Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev. 2006 ; 5: 114-117 (Pubitemid 43129539)
61. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007 ; 66: 1137-1142 (Pubitemid 47309727)
62. Orbach H, Zandman-Goddard G, Amital H, et al. Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci. 2007 ; 1109: 385-400 (Pubitemid 47511381)
63. Amital H, Szekanecz Z, Szücs G, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis. 2010 ; 69: 1155-1157
64. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxic Lett. 2000 ;:
65. Hess EV. Environmental chemicals and autoimmune disease: cause and effect. Toxicology. 2002 ; 181-182: 265-270
66. Zandman-Goddard G, Blank M, Ehrenfeld M, Gilburd B, Peter J, Shoenfeld Y. A comparison of autoantibody production in asymptomatic and symptomatic women with silicone breast implants. JRheumatol. 1999 ; 26: 73-77 (Pubitemid 29051398)
67. Hajdu SD, Agmon-Levin N, Shoenfeld Y. Silicone and autoimmunity. Eur J Clin Invest. 2011 ; 41: 203-211
68. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco on immunity, inflammation and autoimmunity. J Autoimmun. 2010 ; 34: 258-265
69. Agmon-Levin N, Shoenfeld Y. Prediction and prevention of autoimmune skin disorders. Arch Dermatol Res. 2009 ; 301: 57-64
70. Costenbader KH, Kim DJ, Peerzada J, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum. 2004 ; 50: 849-857 (Pubitemid 38326185)
71. Freemer MM, King TE, Criswell LA. Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus. Ann Rheum Dis. 2006 ; 65: 581-584
72. Harel-Meir M, Shoenfeld Y. Predicting and preventive autoimmunity. Myth or reality?. Ann N Y Acad Sci. 2006 ; 1069: 322-345 (Pubitemid 43989876)
73. Vittecoq O, Lequerre T, Goeb V, Le Loet X, Abdesselam TA, Klemmer N. Smoking and inflammatory diseases. Best Pract Res Clin Rheumatol. 2008 ; 22: 923-935
74. Lim S-Y, Ghosh SK. Autoreactive responses to environmental factors: Mouse strain-specific differences in induction and regulation of anti-DNA antibody responses due to phthalate-isomers. JAutoimmun. 2005 ; 25: 33-45 (Pubitemid 41008664)